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Evidence from certain geographical areas links lymphomas of
the ocular adnexa marginal zone B-cell lymphomas (OAMZL)
with Chlamydophila psittaci (Cp) infection, suggesting that
lymphoma development is dependent upon chronic stimulation
by persistent infections. Notwithstanding that, the actual
immunopathogenetical mechanisms have not yet been eluci-
dated. As in other B-cell lymphomas, insight into this issue,
especially with regard to potential selecting ligands, could be
provided by analysis of the immunoglobulin (IG) receptors of
the malignant clones. To this end, we studied the molecular
features of IGs in 44 patients with OAMZL (40% Cp-positive),
identifying features suggestive of a pathogenic mechanism
of autoreactivity. Herein, we show that lymphoma cells express
a distinctive IG repertoire, with electropositive antigen
(Ag)-binding sites, reminiscent of autoantibodies (auto-Abs)
recognizing DNA. Additionally, five (11%) cases of OAMZL
expressed IGs homologous with autoreactive Abs or IGs of
patients with chronic lymphocytic leukemia, a disease known
for the expression of autoreactive IGs by neoplastic cells. In
contrast, no similarity with known anti-Chlamydophila Abs was
found. Taken together, these results strongly indicate that
OAMZL may originate from B cells selected for their capability
to bind Ags and, in particular, auto-Ags. In OAMZL associated
with Cp infection, the pathogen likely acts indirectly on the
malignant B cells, promoting the development of an inflamma-
tory milieu, where auto-Ags could be exposed and presented,
driving proliferation and expansion of self-reactive B cells.
Leukemia (2012) 26, 814–821; doi:10.1038/leu.2011.276;
published online 25 October 2011
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Introduction
Lymphomas arising in the ocular adnexa (conjunctiva, orbit,
eyelid, and lachrymal gland and sac) account for 15% of
extranodal lymphomas.1 Almost all lymphoma categories may
occur in these anatomical structures, but up to 80% of ocular
adnexa lymphomas are represented by extranodal ocular
adnexa marginal zone B-cell lymphomas (OAMZL).2
Extranodal marginal zone lymphomas (EMZL) provide a
valuable ‘in vivo’ model for assessing the actual impact of the
microenvironment in lymphomagenesis. Several lines of
evidence indicate that the development of neoplastic B
lymphocytes is dependent upon chronic stimulation operated
either by autoimmune processes3,4 or persistent infections.5–7
OAMZL exemplifies these concepts, as it has been reported to
be significantly associated, although with variable geographic
prevalence, with Chlamydophila psittaci (Cp) infection.8 Cp is
the etiological agent of human psittacosis, a disease caused by
exposure to infected animals (e.g. birds, cats and other pets). The
key role had by Cp infection in OAMZL pathogenesis has been
further underscored by immunohistochemistry, immunofluores-
cence, electron microscopy, PCR, direct sequencing, in vitro
cultures, and the demonstration of an objective clinical response
following Cp eradication with doxycycline treatment in half of
patients with OAMZL.9,10
The actual mechanisms linking Chlamydiae to OAMZL
development are likely multifaceted,1 though they have not
yet been elucidated. The evaluation of immunoglobulin (IG)
gene repertoire appears an appealing approach to address this
question. Previous analysis of the IG heavy variable (IGHV)
genes in OAMZL demonstrated a restricted repertoire2,11,12 with
mutated genes and ongoing somatic mutations in most
cases,11,13,14 thereby alluding to an origin from an antigen
(Ag)-experienced B lymphocyte, which has undergone Ag
selection. However, all these studies, but one, included p10
investigated cases; in addition, no information on correlation
with infectious agents, Chlamydiae in particular, was provided.
Information about the potential antigenic elements stimulat-
ing neoplastic B-lymphocytes in OAMZL is not available.
Theoretically, antigenic stimulation might be provided either
directly by the bacteria, or indirectly through cellular and
humoral interactions resulting from the inflammatory milieu that
may precede and permeate OAMZL. This speculation is
corroborated by the paradigm of gastric EMZL, where malignant
B lymphocytes do not directly interact with Helicobacter pylori
(Hp),15 but are inappropriately stimulated, via CD40–CD40L
interactions, by activated helper T cells present in the
inflammatory background.16 In addition, neoplastic B cells
are likely to be stimulated by tissue auto-Ags exposed during the
inflammatory process.17
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Molecular analysis of the Ag-binding site of the monoclonal
IG in gastric EMZL confirmed the hypothesis of auto-Ag
engagement, showing a strong similarity of the Ag-binding sites
(heavy complementarity-determining region 3, VH CDR3) of the
expressed B-cell receptors, with those of rheumatoid factors.18
This similarity was also observed in salivary gland EMZL, which
is known to be associated to primary Sjo¨gren’s syndrome, but
not to pulmonary EMZL,18 suggesting that the actual antigenic
stimulation operating in each tissue may differ, despite similar
histological features shared by these clinico-pathological
entities. Accordingly, the immune-mediated interactions occur-
ring in gastric EMZL cannot be a priori transferred to OAMZL
and mechanisms engaged by Cp infection should be elucidated,
as they may not necessarily overlap with those of Hp.19
In the present study, we analyzed the primary IG structure,
and, in particular, the Ag-binding sites (i.e., VH CDR3) of a large
series of OAMZL cases coming from four western countries,
aiming at investigating distinctive features that may be helpful to
get hints about the potential selecting ligands. Our data show
that OAMZL express a distinctive IG repertoire, with VH CDR3
molecular features suggestive of a pathogenic mechanism of
autoreactivity. Interestingly, some cases of OAMZL express IGs
displaying high similarity to that of autoreactive antibodies
(Abs). Taken together, these findings suggest that OAMZL may
arise from B cells selected for their propensity to bind self-Ags,
supporting the hypothesis that stimulation by auto-Ags, likely
provided in the context of an inflammatory reaction triggered by
infectious agents such as Cp, may have a major role in the
process of lymphomagenesis in the ocular adnexa.
Materials and methods
Study group
Forty-four patients with OAMZL, diagnosed according to WHO
classification,20 from France (n¼ 6), Greece (n¼ 9), Italy
(n¼ 23) and USA (n¼ 6) were included in the study. Median
age was 69.5 years old (range 24–90), with a male/female ratio
of 0.83. Chronic infections consisted of gastric Hp infection in 3
of 22 (14%) patients, hepatitis B or C virus in 3 of 29 (10%).
Thirty-two percent of patients (11/34) complained a history
of chronic conjunctivitis. One patient (number 59808000)
reported an overt autoimmune disorder (anti-phospholipid
syndrome). Sites of involvement included conjunctiva in 14
patients (32%), lachrymal gland in 6 (14%) and other soft tissues
of the orbit in the remaining 24 (54%) patients. All tissues were
taken before first-line treatment.
Cp DNA was tested by touchdown enzyme time release–PCR
analysis, as previously reported,21 and confirmed by an
additional PCR protocol amplifying Cp HSP60 (GroEl) gene
sequences.22 The analysis was performed in 38 of 44 OAMZL
patients and showed the presence of the bacteria in 16 of 38
(42%) patients. In the remaining six cases, Cp analysis was not
possible due to lack of material. This study was performed
according to the institutional ethics committee guidelines and
the Declaration of Helsinki.
DNA extraction and PCR amplification of IGHV-D-J
rearrangements
Sections of 5mm thick obtained from formalin-fixed, paraffin-
embedded diagnostic samples underwent DNA extraction using
the QIAamp Tissue Kit (Qiagen, Hilden, Germany) according to
the manufacturer’s recommendations.
PCR amplification of IGHV–D–J genes was performed as
previously described,23,24 using a seminested method. Briefly,
all PCR reactions were carried out first with VH family-specific
FR1 50-primers, together with an external IGHJ consensus
30-primer, for the first amplification round, followed by a
seminested PCR using as template 1 ml of the first amplification
round and substituting the IGHJ 30-primer with a more internal
one. In those cases where the amplification of the IGHV–IGHD–
IGHJ rearrangement was not achieved by the above approach
(35/44), a PCR protocol with an FR2 consensus 50-primer
(instead of FR1 primer) was performed.24 PCR products were run
onto 6% polyacrylamide gels, allowing the detection of
monoclonal rearrangements. To separate the monoclonal
rearrangement from the background of polyclonal rearrange-
ments originating from residual non-malignant B cells, all PCR
products positive for monoclonal IGHV–IGHD–IGHJ gene
rearrangements (as evidenced by the polyacrylamide gel
electrophoresis) were run overnight onto 3% low-melting
agarose gels. The monoclonal bands were identified and excised
with a scalpel under UV lamp, and the DNA was extracted from
the agarose by using QIAquick Gel Extraction Kit (Qiagen)
following the manufacturer’s instructions. The recovered DNA
was directly sequenced on both strands using an automated
DNA sequencer.
Finally, to evaluate the presence of intraclonal diversity, PCR
products from four cases, amplified with the FR2 primer, were
ligated and transferred into TOP10’ bacteria according to
manufacturer’s instructions (original TA-cloning kit, Invitrogen,
Stockholm, Sweden). A colony-direct PCR was performed
(between 11 and 20 reactions per sample) and then directly
sequenced.
Intraclonal diversity among subcloned sequences obtained from
the same sample was assessed by examination of the sequence
variation in the V domain. All ‘non-ubiquitous’ sequence changes
from the germline were evaluated and further characterized as
follows: (i) unconfirmed mutationFa mutation observed in a
single subcloned sequence (‘unique’); (ii) confirmed mutationFa
mutation observed in two or more subcloned sequences (‘partially
shared’) The presence of ongoing mutations was calculated as
percentage using the following formula ‘(confirmedþ
unconfirmed mutations 100)/(IG length number of clones)’ as
previously described.25 Cases with a mutational rate lower than
the expected PCR error rate due to misincorporation by theTaq
DNA polymerase (2 105 per base pair per cycle) were
considered as lacking intraclonal diversity.
IG sequence analysis and interpretation
The quality of the sequences was checked using the VectorNTI
software (Invitrogen, Carlsbad, CA, USA) that allowed
confirming the presence of single nucleotide peaks and the
absence of relevant polyclonal background. Sequence data
were analyzed using the IMGT databases and the IMGT/V-
QUEST tool (http://www.imgt.org). Codons and amino acid
positions are defined according to the IMGT unique numbering
for V domain. To avoid misidentification of mutations when
IGHV FR1 or FR2 consensus primers were used in the
amplification reactions, nucleotide substitutions in the obtained
sequences were evaluated from codon 9 in FR1–IMGT or, for
the sequences obtained with a VH FR2 primer, from codon 48 in
FR2–IMGT, respectively. The downstream end of the analyzed V
region corresponds to the 50-end of the germline CDR3–IMGT as
defined by IMGT/Junction Analysis.
OAMZL IGHV–D–J sequences were aligned to a panel of
13461 unique IGHV–D–J sequences from various types of
normal, autoreactive and malignant B-cell clones, available to
our groups or previously reported in the literature and/or
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retrieved from the IMGT/LIGM-DB sequence database.26 For
such sequences, the accession numbers shared by GenBank,
EMBL-Bank, DNA Data Bank of Japan and IMGT/LIGM-DB are
designated by the ‘GEDI’ abbreviation. This panel included the
following: (i) 7967 sequences from chronic lymphocytic
leukemia (CLL; 7596 from our ‘internal’ database and 371 from
other groups), (ii) 604 sequences from miscellaneous B-cell
lymphoproliferative disorders, (iii) 3326 sequences from normal
B cells, (iv) 364 sequences from ‘immune dysregulation’
disorders (allergy, asthma, various types of immunodeficiency),
and (v) 1200 sequences from autoreactive cells.26 We also
utilized IGHV–D–J sequences of previously reported anti-
Chlamydia Abs.27,28
To comprehensively identify possible restrictions in the VH
CDR3 amino acid composition of the complete data set
(OAMZLþ other entities), we used the TEIRESIAS algorithm,29
a computational tool developed by the Bioinformatics and
Pattern Discovery group at the IBM Computational Biology
Center, freely available from http://cbcsrv.watson.ibm.com/
download.phtml.html. The parameters used in this analysis are
as previously reported.29 The adopted parameters ensured an
extremely high level of sensitivity of the procedure, enabling the
connection of all pairs of sequences that shared at least 50%
amino acid identity and 70% similarity.
Evolutionary history of sets of subcloned sequences
The evolutionary history of the sets of subcloned sequences was
inferred using the maximum parsimony method.30 The consis-
tency index is 1.000 000 (1.000000), the retention index is
1.000 000 (1.000 000), and the composite index is 1.000 000
(1.000 000) for all sites and parsimony-informative sites (in
parentheses). The maximum parsimony tree was obtained using
the close-neighbor-interchange algorithm with search level 0, in
which the initial trees were obtained with the random addition
of sequences (10 replicates). Codon positions included were
1stþ 2ndþ 3rdþ noncoding. All positions containing gaps and
missing data were eliminated.
Statistical methods
Clinical and epidemiological characteristics of studied sub-
groups and distribution of Cp infection were compared using
Fisher’s exact test. Independent associations among studied
variables and Cp infection were assessed by logistic regression.
All statistical tests were two-sided, with a significant ‘P-value’ of
0.05. Analyses were carried out using the Statistica 4.0 statistical
package for Windows (Statsoft Inc, Tulsa, OK, USA).
Results
Biased IGHV gene usage in OAMZL
Forty-six IGHV–IGHD–IGHJ rearrangements were amplified in
44 OAMZL cases, as 2 cases carried double-productive
rearrangements. Clonal PCR products were obtained with FR1
or FR2 primers in 9 and 35 cases, respectively. IGHV3 subgroup
genes predominated (36/46, 78.3%), followed by IGHV4 (8/46,
17.4%) and IGHV1 (2/46, 4.3%) subgroup genes (Table 1). At
the individual gene level, 19 different IGHV genes were utilized.
Of note, only four IGHV3 subgroup genes cumulatively
accounted for 45.7% of the entire series. The most frequent
IGHV gene was IGHV3–23 (8/46, 17.4%), followed by IGHV3–30
(5/46 10.9%), IGHV3–11 and IGHV3–7 (4/46 cases, 8.7%).
Comparison of the IGHV gene repertoire between Cp-positive
and Cp-negative cases did not show significant differences,
likely due to the relatively small numbers of cases in each
subgroup. Similarly, a comparison of the IGHV gene usage
between individual institutions was also not possible.
On the basis of somatic hypermutation status, the rearrange-
ments under study were classified into three different subgroups
as follows: (i) truly unmutated (100% germline identity): 3 of 46
samples (6.5%); (ii) minimally/borderline mutated (97–99.9%
germline identity): 7 of 46 samples (15.2%); and (iii) signifi-
cantly mutated (o97% identity): 36 of 46 samples (78.3%). The
majority of mutations occurred in CDRs rather than FRs; in
addition, most CDR mutations were R rather than S, leading to
high R/S ratios (5.22) in CDR2 and, vice versa, low R/S ratios
(1.88) in FR3, in keeping with a canonical SHM process.
Intraclonal diversity in rearranged IGHV genes was analyzed in
four cases (11–20 subcloned sequences per sample). All nucleotide
mutations from the germline were taken into account and were
subdivided into confirmed or unconfirmed (following the defini-
tions provided in the Materials and methods section). Confirmed
mutations leading to intraclonal diversity were detected in two of
four cases (cases number JN182372 and number JN182360 in
Table 2 and Figure 1), with an overall nucleotide substitution rate
of 0.39 and 0.61%, respectively. In both cases, the sequences
obtained from cloning differed by up to three nucleotides from the
sequence obtained with direct sequencing.
Hints for autoreactivity from the analysis of VH CDR3
sequences
A reliable VH CDR3 sequence was obtained in 44 of 46
IGHV-D-J rearrangements from OAMZL. IGHD genes were
identified in 43 of 44 cases; the most frequent IGHD subgroup
was IGHD3 (19/43, 44.2%). Seventeen IGHD genes were
identified; the IGHD3–3 gene predominated (10/43 cases,
23.3%). In keeping with the normal adult B-cell repertoire, the
IGHJ4 and IGHJ6 genes predominated (16 and 11 cases,
respectively).
VH CDR3 length ranged from 8 to 30 amino acids (median,
15). Interestingly, 30 of 44 HCDR3 sequences had a predicted
isoelectric point (pI) value of greater than 6.0, (18/44 with pI
values 48.0), a feature shared also by Abs with anti-DNA
activity.31
Cluster analysis of the VH CDR3 amino-acid sequences
within the OAMZL data set did not reveal sequence restrictions.
In contrast, when the same approach included sequences from
other entities, we observed that OAMZL rearrangements
clustered against some other sequences on the basis of a high
VH-CDR3 similarity (Table 3). In particular, one Cp-positive
OAMZL case carried VH CDR3 homologous to that of a B-cell
clone derived from a patient affected by rheumatoid arthritis;
another OAMZL case, again Cp-positive, carried VH CDR3
homologous to the IG expressed by a B-cell clone from a patient
with primary Sjo¨gren’s syndrome; two additional OAMZL cases
both Cp-negative, showed VH CDR3 homology to CLL mAbs.
Finally, one Cp-positive OAMZL case (number JN182384)
showed homology to multiple sequences, creating a distinctive
cluster. This case carried a IGHV3–7/IGHD3–22/IGHJ3 rear-
rangement that, based on shared VH CDR3 patterns, was similar
to six rearrangements utilizing the same IG genes and expressed
by the following B-cell clones from: (i) a gastric EMZL (GEDI/
AY281326); (ii) a salivary gland EMZL (GEDI/AF216825); (iii) a
hepatitis C virus-associated diffuse large B-cell lymphoma
(GEDI/AF303909); (iv) a rheumatoid factor from a healthy
individual immunized with mismatched red blood cells (GEDI/
U85242); (iv) two CLL cases (NL-01-0121 and NL-01-0591).
IGHV gene repertoire in OAL
A Dagklis et al
816
Leukemia
Table 1 Patient characteristics, Cp infection status and IGHV gene usage in OAMZL
GenBank accession number Gender Age Clinical stagea Site Cp infection IGHV gene IMGT (%)b
JN182346 M 74 I Lachrymal gland NT IGHV3–66*02 99.23
JN182347 F 58 I Conjuctiva NT IGHV3–9*01 91.29
JN182348 M 85 I Orbit NT IGHV4–4*02 93.18
JN190950 M 64 I Orbit NT IGHV4–59*08 94.97
JN182349 F 24 I Conjuctiva NT IGHV3–11*01 95.71
JN182350 F 63 I Orbit NT IGHV3–30*04 97.55
JN182351 F 66 I Orbit NEG IGHV4–59*07 95.57
JN182352 M 47 I Orbit NEG IGHV3–73*01 88.02
JN182353 M 74 I Orbit NEG IGHV4–34*01 93.75
JN182354 F 79 I Lachrymal gland NEG IGHV3–23*03 91.88
JN182355 M 88 I Orbit NEG IGHV3–48*01 92.73
JN182356 M 78 I Orbit NEG IGHV3–23*01 93.94
JN182357 F 75 I Orbit NEG IGHV3–11*01 96.86
JN182358 F 64 IV Lachrymal gland POS IGHV3–23*01 93.12
JN182359 F 65 I Orbit–conjuctiva POS IGHV1–69*01 91.41
JN182360 F 80 I Orbit POS IGHV3–7*01 93.87
JN182361 F 82 IV Orbit POS IGHV4–31*03 95.62
JN182362 M 39 I Conjunctiva NEG IGHV3–64*05 98.16
JN182363 F 78 I Conjunctiva NEG IGHV3–23*01 89.57
JN182364 M 48 I Lachrymal gland NEG IGHV4–34*01 100
JN182365 M 48 IV Orbit NEG IGHV3–23*01 88.34
JN182366 F 86 I Orbit NT IGHV3–21*01 98.77
JN182367 M 51 I Orbit NEG IGHV3–43*01 94.48
JN182368 F 78 I Orbit POS IGHV3–23*01 93.87
JN182369 F 25 I Conjunctiva POS IGHV3–11*03 95.09
JN182370 F 74 I Orbit POS IGHV3–43*01 94.48
JN182371 F 68 I Conjunctiva NEG IGHV3–7*01 93.87
JN182372 F 50 I Conjunctiva POS IGHV3–7*01 94.48
JN182373 M 74 IV Conjunctiva NEG IGHV3–48*03 93.25
JN182374 M 56 I Orbit POS IGHV3–48*01 98.77
JN182375 M 43 I Orbit POS IGHV3–30*06 93.25
JN182376 F 55 I Conjunctiva POS IGHV3–15*01 91.72
JN182377 F 68 I Orbit POS IGHV3–33*01 89.57
JN182378 M 75 I Orbit NEG IGHV3–30*03 95.76
JN182379 M 42 I Conjunctiva POS IGHV4–59*02 100
JN182380 IGHV3–15*01 97.04
JN182381 M 80 I Orbit NEG IGHV3–23*01 94.48
JN182382 IGHV3–43*01 91.41
JN182383 F 61 I Lachrymal gland POS IGHV3–30*03 95.09
JN182384 F 55 I Orbit POS IGHV3–7*01 98.79
JN182385 M 90 I Lachrymal gland NEG IGHV3–11*01 100
JN182386 F 72 I Eyelid NEG IGHV4–34*02 87.79
JN182387 M 74 I Conjunctiva NEG IGHV3–74*01 94.34
JN182388 F 75 IV Conjunctiva NEG IGHV1–69*01 96.98
JN182389 M 71 IV Conjunctiva NEG IGHV3–23*01 92.38
JN182390 F 82 I Orbit NEG IGHV3–30*03 88.68
Abbreviations: Cp, Chlamydophila psittaci; F, female; IGHV, immunoglobulin heavy variable gene; IMGT, ImMunoGeneTics; M, male; NEG,
negative; NT, not tested; OAMZL, ocular adnexa marginal zone B-cell lymphomas; POS, positive.
aAnn Arbor.
bPercentage of identity with the closest germline IGHV gene.
Table 2 Intraclonal diversity in rearranged IGHV genes in OAMZL










JN182372 11 1793 4 3 0.39
JN182360 15 2445 11 4 0.61
JN182370a 20 3260 0 19 NA
JN182376b 13 2119 0 2 0.09
Abbreviations: IGHV, immunoglobulin heavy variable gene; NA, not applicable; OAMZL, ocular adnexa marginal zone B-cell lymphomas.
aIn this case, all mutations were present in a single clone, and the possibility exists that they are due to a PCR artifact. Thus, they were considered
‘unconfirmed’ and not included in the analysis.
bThis case had a mutational rate lower than the expected experimental error frequency due to Taq DNA polymerase (2105 per base pair per
cycle); thus, it was considered as if it did not show intraclonal diversity.
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c172>t, Q58>S (- - -)
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Colonies 2, 5, 8, 9, 11
Figure 1 Clonal evolution trees. The evolutionary history of both OAMZL cases with clear evidence for intraclonal diversification (i.e., carrying
confirmed mutations) was inferred drawing clonal evolution trees that were constructed by MEGA5 algorithms and tools. (a) Case JN182360;
(b) Case JN182372.
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Interestingly, no structural similarities between IGs expressed
by OAMZL in the present study and the structure of Abs specific
for Chlamydiae27,28 could be demonstrated.
Discussion
This molecular study of the IGs expressed by neoplastic B cells
in OAMZL, so far the largest available, provides new informa-
tion on distinctive features that may be helpful for understanding
the role of antigenic stimulation in this malignancy. The main
findings of this study embrace a restriction of IGHV gene usage,
likely due to an antigenic exposure, with a strong bias in the
usage of IGHV3–23, IGHV3–30, IGHV3–11 and IGHV3–7
genes, and a high homology between IG sequences (mainly, but
not exclusively from Cp-positive OAML) and previously
reported autoreactive Abs. This suggests a scenario where the
B-cell receptors carried by OAMZL neoplastic B cells is not
directed against Cp, but rather against auto-Ags exposed in non-
neoplastic, reactive milieu accompanying the lymphoma.
OAMZL, in particular those associated with Cp infection,
represent an intriguing model for studying the process of
lymphomagenesis.1 Further support for this concept is provided
by the fact that many OAMZL cases have a previous history of
conjunctivitis,32 indicating that an inflammatory/immune pro-
cess taking place in the ocular adnexa is likely to have a critical
role in the onset and maintenance of the disease by stimulating
responsive B cells. In line with these observations: (i)
Chlamydiae have been directly visualized within monocytes/
macrophages present in lymphomatous lesions;33 (ii) viable and
infectious Cp have been isolated in conjunctival swabs from
OAMZL patients32 and, (iii) clinical responses have been
obtained with Cp-eradicating antibiotic therapy.9 Notwithstand-
ing these achievements, the precise mechanisms of antigenic
stimulation are not yet fully elucidated and could theoretically
evoke a direct role of still unidentified bacterial Ags and/or the
indirect triggering by unrelated antigenic element(s) exposed
within the context of the tissue inflammation.34
In the present study, the predominant usage of IGHV3
subgroup genes (78.3%) and, mostly, the preferential usage of
four IGHV genes, accounting for almost half of cases, allude to
selection of IGHV specificities by antigenic exposure.2,11–14
Previous studies on more limited series2,11–14 indicated that the
IGHV3–23 and IGHV3–7 genes were the predominant IGHV
genes in ocular adnexal lymphomas, albeit their overall
combined frequency was rather low (10.6% in total). At a
variance with these figures, we herein demonstrate a strong bias
in the usage of these two genes that cumulatively account for
26% of the series. This finding, together with the presence of
somatic mutations and the observed somatic hypermutation
patterns, allows to conceive that the cell of origin may be an Ag-
experienced B cell, which has undergone an Ag-based selection
process, as also suggested by previous publications.2,11–14
In addition to the high mutational load, intraclonal diversity in
rearranged IGHV genes was observed in two of four cases
analyzed, suggesting that the malignant clones may still be
under the influence of hypermutational mechanism, very likely
within the context of Ag-driven stimulation. These data are in
concordance with previous studies11–14 showing that also
EMZLs derived from post-GC B cells can show ongoing
mutations.
The present study provides for the first time molecular data
concerning the relationship between IGHV gene repertoire and
Cp infection in OAMZL. Due to the relatively small number of
clones utilizing each particular IGHV gene, we could not reach
definitive conclusions on potential repertoire differences be-
tween Cp-positive versus Cp-negative cases that would offer
insight into the role had by this infection in shaping the IG
receptors in ocular adnexal lymphomas. Several additional
factors should also be kept into consideration, as potential
confounding elements in this analysis, including the possibility
that other, not yet identified, microorganisms may be also
involved, the presence of samples originating from different
geographical regions and the reduction of bacterial load in
lymphoma samples due to use of local antibiotics therapy before
diagnostic biopsy.
Prompted by the observed IGHV gene restrictions, we also
sought to analyze in detail, through a bioinformatics approach,
the molecular structure of the Ag-binding sites (VH CDR3s) of
the IG receptors expressed by the OAMZL in our series. By this
approach, we obtained significant, though admittedly indirect,
molecular evidence, suggesting that, at least in a proportion of
Table 3 VH CDR3 similarity between OAMZL and unrelated sequences
Case IGHV VH CDR3 Diagnosis
JN182365 IGHV3–23 ANRNGSSPSYYFDY OAMZL
AY393382 IGHV2–5 – H–Q – –––– –GL–V Rheumatoid arthritis
JN182359 IGHV1–69 ARGPGDTNTYYYFY OAMZL
AF038446 IGHV1–69 –––––––NSG––––– Primary Sjogren’s syndrome
JN182384 IGHV3–7 ARGDYYDSSGYYHDAFDI OAMZL
AY281326 IGHV3–7 –––––F––––––SF I – –––– Gastric malt lymphoma
AF216825 IGHV3–7 ––––––––––––FS–––––T Salivary gland malt lymphoma
AF303909 IGHV3–7 ––––––––T–––FS–––––– DLBCL, HCV-related
U85242 IGHV3–7 –––––––––––N–––––––V Rheumatoid factor
NL-01-0121 IGHV3–7 –––––F–E––––N––––––V CLL
NL-01-0591 IGHV3–7 –––––F–DT––FN––––––– CLL
JN182388 IGHV1–69 AREFASDSSGYYYYY OAMZL
UK-02-0059 IGHV1–69 –––G–G–––––––FF– CLL
NY-01-0831 IGHV1–69 ––G–DYE––––––––– CLL
JN182354 IGHV3–23 AKPYYDFWSGYSTSWFDP OAMZL
UK-01-0470 IGHV3–23 ––E––––––––––GRL––Y CLL
Abbreviations: CLL, chronic lymphocytic leukemia; DLBCL, diffuse large B-cell lymphoma; IGHV, immunoglobulin heavy variable gene;
HCV, hepatitis C virus; OAMZL, ocular adnexa marginal zone B-cell lymphomas; VH CDR 3, heavy complementarity determining region 3.
Functionally equivalent amino acids are highlighted in grey. Dashes indicate identities.
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cases, the antigenic elements recognized by the malignant
clones may potentially be auto-Ags.
Though it is known that IG specificity cannot be predicted by
sequence analysis alone, the comparison of IG sequences with
other Abs of known specificity could provide useful hints. We
took advantage of a large available panel of unique IGHV-D-J
rearrangements from neoplastic and non-neoplastic B cells,
including autoreactive clones,26 and compared them with the
IG sequences, in particular, the VH CDR3 sequences utilized by
our OAMZL cases. Our intentional focus on VH CDR3
sequences is justified by its impact on Ag recognition, with
transgenesis,35 structural36 and functional37 studies, indicating
that VH CDR3 sequences act often as the major factor of
specificity in Ag recognition.
No IG sequence ‘stereotypy’38 (i.e., sequence identity or
similarity) could be found within the OAMZL IG gene
sequences. However, 11.3% (5/44) of cases carried IGs that
were found to be homologous with Abs from other entities.
Interestingly, three of these Abs were autoreactive, and all were
similar to the IGs obtained from Cp-positive OAMZL. Interest-
ingly, case number JN182365 (Table 3) utilized a different IGHV
gene from the homologous Ab, though sharing a similar VH
CDR3 sequence. This finding is not unexpected, due to the fact
that the contribution of the IGHV gene to CDR3 is much less
extensive (2–3 aminoacids) when compared with that of the
IGHD and IGHJ genes. At this point it is also worth underscoring
the fact that heavy CDR1/CDR2 loops adopt a small number of
main chain conformations,39 meaning that different germline
IGHV genes may in fact adopt a similar structure. Furthermore,
our finding is also not unprecedented, as exemplified by CLL,
where different cases utilizing distinct IGHV genes may show
stereotyped VH CDR3s, especially so when they are phylogen-
etically related.29 Overall, homology in VH CDR3 sequences
implies selection by a similar, if not identical, antigenic element
rather than a random association of a particular IGHV gene,
simply occurring because of the usage of identical IGHV gene
sequences.
One of these OAMZL cases carried a highly similar VH CDR3
with Abs amplified in a case of rheumatoid arthritis, and one
each gastric EMZL and hepatitis C virus-related lymphoma,
respectively, suggesting that common patterns of stimulation by
unrelated or cross-reactive pathogens or auto-Ags can lead to
strikingly different B-cell disorders, likely depending on the
stage of lymphocyte differentiation or the anatomical site of
antigenic exposure. Moreover, two Cp-positive OAMZL cases
carried a similar VH CDR3 with IGs expressed in CLL, a disease
where leukemic cells often express autoreactive IGs.40,41 Along
the same lines, it is worth underscoring the fact that at least two-
thirds of investigated OAMZL cases carried electropositive VH
CDR3 sequences, similar to Abs with anti-DNA activity,31 thus
alluding to hitherto unknown auto-Ag recognition for the
majority of OAMZLs.
Our present findings are highly reminiscent of those obtained
in gastric EMZL18 and CLL.41 In the former case, similarities
between the monoclonal IG and Abs with rheumatoid factor
activity were observed in 18% of cases,18 whereas in the case of
CLL, several clonotypic IG receptors have been proven similar
to Abs reactive toward different auto-Ags, including IgG,
cardiolipin and DNA.41
Taken together, the molecular findings reported herein
strongly support, though indirectly, the hypothesis that OAMZL
may originate from B cells selected for their capability to bind
Ags, in particular auto-Ags. In addition, they justify drawing for
OAMZL a scenario that closely recapitulates what happens in
gastric EMZL, where the B-cell receptors carried by neoplastic B
cells is not directed against Hp, but rather against auto-Ags.17,18
In this model, Cp likely acts indirectly on the malignant B cells,
promoting the development of an inflammatory milieu, where
auto-Ags could be exposed and presented, driving proliferation
and expansion of self-reactive B cells.15 This hypothesis is
further supported by the lack of structural similarities between
IGs expressed by investigated cases of OAMZL and the structure
of Abs specific for Chlamydiae,28 suggesting that antigenic
elements differing from bacterial epitopes may shape the IG
gene repertoire.
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